FDA Inspection 1057479 — Anne-Sofie Krogsaa, MD
The FDA completed an inspection of Anne-Sofie Krogsaa, MD on June 14, 2018 in Ballerup. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 14, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ballerup (Denmark)
Additional Details
Clinical Investigator (CI)